FDA approves drug to treat dogs with idiopathic epilepsy

The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
Mad in America

None of the 22 FDA Approvals for Psychiatric Drugs in the Last Decade Were “Clinically Useful”

Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
Ophthalmology Times

FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
CURE

Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma

Dr. Myron Czuczman highlighted the significance of the recent U.S. Food and Drug Administration (FDA) approval of Lymphir ...
CURE

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
Marijuana Moment

West Virginia And Mississippi Lawmakers Approve Psychedelics Bills To Fund Ibogaine Trials Toward FDA Approval

The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...
Healio

FDA approves updated label with new dosing guidance for inhaled insulin

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
dvm360

FDA grants full approval for canine idiopathic epilepsy medication

FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
MedTech Dive

Grail files for FDA approval of multi-cancer early detection test

Amid the upheaval, Grail continued to run studies to assess the ability of its Galleri blood test to detect a range of ...
Ophthalmology Times

FDA approves NDA labeling supplement allowing re-administration of iDose TR

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
Becker's Hospital Review

FDA delays approval for anaphylaxis drug

The FDA has delayed approval of Aquestive Therapeutics’ new drug application seeking approval of Anaphylm, a sublingual epinephrine film for the treatment of Type 1 allergic reactions, including ...